Invention Application
- Patent Title: Anti-CLL-1 Antibodies and Methods of Use
-
Application No.: US16658706Application Date: 2019-10-21
-
Publication No.: US20200148774A1Publication Date: 2020-05-14
- Inventor: Robert F. Kelley , Steven R. Leong , Wei-Ching Liang , Mary Mathieu , Andrew G. Polson , Bing Zheng , Xiaocheng Chen , Cecilia Pui Chi Chiu , Mark S. Dennis , Allen Ebens , Yan Wu
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/30 ; A61K39/395 ; A61K45/06
Abstract:
The present invention relates to anti-CLL-1 antibodies including anti-CLL-1 antibodies comprising a CLL-1 binding domain and a CD3 binding domain (e.g., anti-CLL-1/CD3 T cell dependent bispecific (TDB) antibody) and methods of using the same.
Public/Granted literature
- US11466087B2 Anti-CLL-1 antibodies and methods of use Public/Granted day:2022-10-11
Information query
